Literature DB >> 34267867

The use of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography integrated with computed tomography for accurate staging and surveillance in the case of mucosa-associated lymphoid tissue.

Shunqing Zhang1, Allen Rossetti-Chung1, Sumit Sood1, Stephanie Terezakis1.   

Abstract

We present the case of a 79-year-old male, who was initially treated for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) of the right eyelid, and later for disease relapse in the stomach. During follow up, he was noted to have developed left arm nodules just medial to the proximal biceps muscle, which were found to be multiply enlarged lymph nodes on subsequent ultrasound imaging. Excisional biopsy of these nodes revealed MALT lymphoma. He was initially referred for consideration of radiation, but a restaging F-18 fluorodeoxyglucose positron emission tomography integrated with computed tomography (F-18 FDG PET/CT) further identified a focus of suspicious uptake in left calf, which was later also biopsy proven to be MALT lymphoma. His disease was upstaged as the result of this later finding, and the overall recommendation for treatment changed to favor systemic treatment with Rituximab. Copyright Journal of Radiology Case Reports.

Entities:  

Keywords:  Extranodal marginal zone B-cell lymphoma; Marginal zone lymphoma of MALT; PET/CT; field of view; mucosa-associated lymphatic tissue (MALT) lymphoma

Year:  2021        PMID: 34267867      PMCID: PMC8253150          DOI: 10.3941/jrcr.v15i3.4193

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  23 in total

1.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

Authors: 
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

Review 2.  Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed.

Authors:  C Thieblemont; F Berger; C Dumontet; I Moullet; F Bouafia; P Felman; G Salles; B Coiffier
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 3.  The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

Authors:  Emanuele Zucca; Francesco Bertoni
Journal:  Blood       Date:  2016-03-17       Impact factor: 22.113

4.  Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.

Authors:  Jayant S Goda; Mary Gospodarowicz; Melania Pintilie; Woodrow Wells; David C Hodgson; Alexander Sun; Micheal Crump; Richard W Tsang
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

5.  Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.

Authors:  Markus Raderer; Stefan Wöhrer; Berthold Streubel; Marlene Troch; Karl Turetschek; Ulrich Jäger; Cathrin Skrabs; Alexander Gaiger; Johannes Drach; Andreas Puespoek; Michael Formanek; Martha Hoffmann; Wolfgang Hauff; Andreas Chott
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

6.  Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.

Authors:  Shunan Qi; May Y Huang; Yong Yang; Heiko Schöder; Sewit Teckie; Ariela Noy; Karen Chau; Joachim Yahalom
Journal:  Blood Adv       Date:  2018-03-27

7.  (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

Authors:  Michal Weiler-Sagie; Olga Bushelev; Ron Epelbaum; Eldad J Dann; Nissim Haim; Irit Avivi; Ayelet Ben-Barak; Yehudit Ben-Arie; Rachel Bar-Shalom; Ora Israel
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

8.  Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.

Authors:  Chava Perry; Yair Herishanu; Ur Metzer; Osnat Bairey; Rosa Ruchlemer; Leonor Trejo; Elizabeth Naparstek; Einat Even Sapir; Aaron Polliack
Journal:  Eur J Haematol       Date:  2007-07-27       Impact factor: 2.997

9.  Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.

Authors:  Richard W Tsang; Mary K Gospodarowicz; Melania Pintilie; Woodrow Wells; David C Hodgson; Alexander Sun; Michael Crump; Bruce J Patterson
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

10.  Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Zucca; L Arcaini; C Buske; P W Johnson; M Ponzoni; M Raderer; U Ricardi; A Salar; K Stamatopoulos; C Thieblemont; A Wotherspoon; M Ladetto
Journal:  Ann Oncol       Date:  2019-12-04       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.